EGFR inhibitor (Acerand Therapeutics)

N/A

Report date: 2025/06/11 11:02:32
NME

Base Information

Drug NameEGFR inhibitor (Acerand Therapeutics)
Drug Alias NameACE-34237307
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcerand Therapeutics (USA) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAcerand Therapeutics (USA) Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A